Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allogeneic T cell activation triggering by MHC class I antigens.

S Chouaib1, A Bensussan, A M Termijtelen

  • 1Laboratoire d'Immunologie, UA1156 CNRS, Villejuif, France.

Journal of Immunology (Baltimore, Md. : 1950)
|July 15, 1988
PubMed
Summary

Human leukocyte antigen (HLA) class I disparities initiate early T cell activation and prime cytotoxic T cells. Blocking these HLA class I antigens inhibits T cell responses, highlighting their critical role in allogeneic T cell activation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vitro effects of wound-dressings on key wound healing properties of dermal fibroblasts.

Experimental dermatology·2024
Same author

The value of five blood markers in differentiating mycosis fungoides and Sézary syndrome: a validation cohort.

The British journal of dermatology·2020
Same author

Revisiting the initial diagnosis and blood staging of mycosis fungoides and Sézary syndrome with the KIR3DL2 marker.

The British journal of dermatology·2019
Same author

Cutaneous presentation of adult T-cell leukemia/lymphoma (ATLL). Single-center study on 37 patients in metropolitan France between 1996 and 2016.

Annales de dermatologie et de venereologie·2018
Same author

KIR3DL2 expression in patients with adult T-cell lymphoma/leukaemia.

The British journal of dermatology·2018
Same author

Study of gene expression alteration in male androgenetic alopecia: evidence of predominant molecular signalling pathways.

The British journal of dermatology·2017

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Major histocompatibility complex (MHC) class I molecules are crucial for immune responses.
  • Their role in allogeneic T cell activation and proliferation requires further elucidation.

Purpose of the Study:

  • To investigate the role of MHC-encoded class I molecules in allogeneic T cell activation and proliferation.
  • To determine if MHC class I disparity alone can trigger T cell responses.

Main Methods:

  • Primary mixed lymphocyte cultures using MHC recombinant siblings with class II identity but class I disparity.
  • Flow cytometry to assess cell cycle entry (G0-G1), IL-2 receptor (IL-2R) expression, and transferrin receptor expression.
  • Assay for IL-2 activity and cytotoxic T lymphocyte (CTL) differentiation.

Related Experiment Videos

  • Inhibition studies using W6/32 monoclonal antibody against HLA class I antigens.

    • Main Results:

    • MHC class I disparity induced early T cell activation, including cell cycle entry and IL-2R expression, without significant proliferation.
    • MHC class I disparity primed precursor CTLs into IL-2-dependent, MHC-restricted cytotoxic T cells.
    • Exogenous IL-1 did not enhance IL-2 production or proliferation, suggesting intact accessory cell function.
    • IFN-gamma had no effect on these responses.
    • The W6/32 antibody blocked all observed activation events mediated by MHC class I disparity.

    Conclusions:

    • HLA class I antigens play a significant role in initiating early allogeneic T cell activation.
    • MHC class I disparity is sufficient to trigger early activation steps and prime cytotoxic T cells.
    • Targeting HLA class I molecules offers a potential strategy for modulating allogeneic immune responses.